These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9810920)
1. Melanoma-in-transit presenting as panniculitis. Cotton J; Armstrong DJ; Wedig R; Hood AF J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):876-8. PubMed ID: 9810920 [TBL] [Abstract][Full Text] [Related]
2. Effective therapy: repeat limb perfusion for recurrent melanoma. Krementz ET J Am Coll Surg; 1996 Jun; 182(6):547-8. PubMed ID: 8646356 [No Abstract] [Full Text] [Related]
3. Surgical issues in the management of melanoma. Fraker DL Curr Opin Oncol; 1997 Mar; 9(2):183-8. PubMed ID: 9161799 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557 [TBL] [Abstract][Full Text] [Related]
12. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma. Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166 [TBL] [Abstract][Full Text] [Related]
13. One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases. Grünhagen DJ; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM Ann Surg; 2004 Dec; 240(6):939-47; discussion 947-8. PubMed ID: 15570199 [TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment and regional chemotherapy in melanoma of the extremities]. Henneking K; Binder J; Weyers W; Schwemmle K Chirurg; 1993 Feb; 64(2):134-8. PubMed ID: 8462350 [TBL] [Abstract][Full Text] [Related]
15. Multiple basal cell carcinomas of the limb after adjuvant treatment of melanoma with isolated limb perfusion. Lamb PM; Menaker GM; Moy RL J Am Acad Dermatol; 1998 May; 38(5 Pt 1):767-8. PubMed ID: 9591826 [No Abstract] [Full Text] [Related]
16. Results of isolated lower limb perfusion for loco-regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases. Pace M; Gattai R; Mascitelli EM; Millanta L J Surg Oncol; 2011 Dec; 104(7):718-23. PubMed ID: 21721008 [TBL] [Abstract][Full Text] [Related]
18. [Risk factors for the development of lymphatic fistula after ilioinguinal lymph node dissection before isolated limb perfusion and its potential clinical relevance]. Mohr Z; Hirche C; Gretschel S; Bembenek A Zentralbl Chir; 2011 Aug; 136(4):386-90. PubMed ID: 21341181 [TBL] [Abstract][Full Text] [Related]
19. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial. Olofsson Bagge R; Mattsson J; Hafström L Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study. Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]